CDLX
Cardlytics Inc
3.80$
-3.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.6% | +16.0% | +52.6% | +45.9% | +88.4% | +199.1% | -45.3% | -16.9% | -31.6% | -27.3% | |
| – | +0.4% | +9.2% | +66.6% | +57.4% | +97.0% | -7.0% | -30.3% | -10.4% | -20.5% | -22.9% | |
| – | -16.4% | -6.9% | +86.4% | +163.6% | +180.7% | -20.4% | -47.8% | -24.7% | -28.6% | -25.7% | |
| – | -16.4% | -6.9% | +86.4% | +163.6% | +180.7% | -20.4% | -47.8% | -24.7% | -28.6% | -25.7% | |
| – | +12.0% | +17.0% | +18.1% | +41.0% | +1.4% | +35.4% | +2.5% | +4.9% | -15.0% | -20.4% | |
| – | -54.5% | – | – | -99.4% | -14.7% | -13.6% | -15.8% | – | – | – | |
| – | -12.6% | -12.3% | +39.8% | +39.7% | -3.0% | +54.8% | -72.4% | – | – | – | |
| – | – | – | – | – | – | – | -52.5% | -21.4% | -42.5% | -30.8% | |
| – | -56.5% | +101.9% | +107.6% | +110.7% | +60.5% | +1,955.8% | -47.1% | -18.7% | -80.9% | -51.2% | |
| – | +24.2% | +1.9% | -67.1% | -20.4% | +227.4% | +116.0% | -16.3% | -8.4% | -26.5% | -9.5% | |
| – | -41.1% | +6.4% | +23.2% | +51.0% | +3.7% | +302.8% | -24.0% | -31.3% | -13.0% | -47.4% | |
| – | -99.6% | -55.6% | -52.3% | +14.3% | +19,558.3% | +27.8% | -18.5% | -56.5% | +2,140.9% | -96.6% | |
| – | -45.9% | -34.4% | +35.1% | -41.4% | +10.9% | +238.9% | -18.5% | +17.5% | -16.6% | -8.9% | |
| – | +775.5% | -49.0% | -18.0% | -100.0% | +1,338,446.2% | +6.0% | +22.6% | +13.9% | -34.9% | +24.6% | |
| – | – | – | – | +175.6% | +9.7% | +339.4% | -69.4% | -36.3% | -48.1% | -109.3% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +39.2% | -90.2% | +24.6% | +14.6% | +18.3% | +3.8% | +9.2% | +32.5% | +9.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.